Recombinant Human MIXL1 Protein, N-GST & C-His from ProteoGenix; catalogue ARO-P11354; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Human MIXL1 Protein is a highly purified and biologically active protein that is produced through the process of recombinant DNA technology. This protein is a member of the Mix/Bix family of transcription factors and is involved in the regulation of early embryonic development and cell differentiation. In this article, we will explore the structure, activity, and applications of Recombinant Human MIXL1 Protein.
Recombinant Human MIXL1 Protein is a 17 kDa protein that is composed of 147 amino acids. It contains a homeobox domain, which is a conserved DNA-binding domain that is found in many transcription factors. This domain is responsible for the binding of Recombinant Human MIXL1 Protein to specific DNA sequences, allowing it to regulate the expression of target genes. In addition, this protein also contains a C-terminal transactivation domain, which is important for its transcriptional activity.
Recombinant Human MIXL1 Protein is a transcription factor that plays a crucial role in the early stages of embryonic development. It is involved in the formation of the mesoderm, which is one of the three primary germ layers that give rise to different tissues and organs in the developing embryo. This protein is also important for the differentiation of mesodermal cells into various cell types, such as muscle, bone, and blood cells.
Recombinant Human MIXL1 Protein exerts its activity by binding to specific DNA sequences in the regulatory regions of target genes. This binding leads to the activation or repression of gene expression, depending on the context. Through its transcriptional activity, this protein is able to control the expression of a wide range of genes that are involved in cell fate determination and differentiation.
Recombinant Human MIXL1 Protein has a wide range of applications in both basic research and biotechnology. In basic research, this protein is used to study the mechanisms of early embryonic development and cell differentiation. Its ability to regulate gene expression makes it a valuable tool for investigating the roles of different genes in these processes.
In biotechnology, Recombinant Human MIXL1 Protein has potential applications in regenerative medicine. Its role in the differentiation of mesodermal cells makes it a promising candidate for promoting tissue repair and regeneration. In addition, this protein has also been studied for its potential in cancer therapy, as it has been shown to inhibit the growth of certain types of cancer cells.
Recombinant Human MIXL1 Protein is a biologically active protein that plays a crucial role in early embryonic development and cell differentiation. Its structure, which includes a homeobox domain and a transactivation domain, allows it to bind to specific DNA sequences and regulate the expression of target genes. This protein has a wide range of applications in basic research and biotechnology, making it a valuable tool for studying embryonic development and potentially contributing to the development of new therapies for various diseases.
ProteoGenix catalogue number ARO-P11354. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 34.59 kDa; Fragment: Ser94-Gly146; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
